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Connective tissue mast cells (CTMC) reside near to blood vessels in connective
tissues andare found also in the peritoneal cavity in many species (1) . Once thought
to be terminally differentiated cells,CTMC arenowknownto proliferate in response
to activated spleen cell-conditioned medium (SCCM) or to a mixture of IL-3 and
IL-4 (2, 3) . CTMC, which contain large quantities of heparin and histamine, are
distinguished from mucosal mast cells (MMC), which are found in the digestive
tract, contain little histamine, and have granules that contain chondroitin sulfate
E as opposed to heparinproteoglycan .Athird related cell type, the circulating basophil,
shares some properties with mucosal mast cells but is not considered identical to
eitherMMC orCTMC (1) . Although, basophils andbasophilic leukemia cells have
been shown to migrate toward specific stimuli such as IFN (4), IgE (5), and to
undefined factors released from activated lymphocytes (6), little is known concerning
the regulation of cell migration in connective tissue mast cells . In the current study,
we have tested SCCM as well as purified lymphokines known to stimulate mast cell
proliferation for their effects on CTMC migration .
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Reagents.
￿
Recombinantand purified natural murine IL-2, IL-3,and IL-4 and granulocyte-
macrophage CSF (GM-CSF) were obtained from Genzyme, Boston, MA. 1 U of IL-2 ac-
tivity is defined as the amount required to support half-maximal [3H]TdR incorporation by
CTLL-2 cells. 1 U of IL-3 activity is described as the amount required to stimulate half-
maximal activity ofFDC-P2 cells as described by Prestidge et al . (7) . GM-CSF activity was
established using FDC-P21D cells by the same method . IL-4 activity was defined on the basis
of murine B cell proliferation assays according to the method ofGrabstein et al . (8) . Glycyl-
histidyl-lysine was from Calbiochem-Behting Corp. (San Diego, CA), and N-formyl-methionyl-
leucyl-phenylalanine and endotoxin (Escherichia coli LPS) was from Sigma Chemical Co. (St .
Louis, MO) . PWM (Gibco Laboratories, Grand Island, NY)-stimulated SCCM was pre-
pared according to the method ofNakahata andOgawa (9) . Monoclonal rat anti-mouse IL-3
(IgG2a ; 10) was generously provided byDr. John Abrams, DNAX Research Intitute ofMo-
lecular and Cellular Biology, Palo Alto, CA . To neutralize IL-3 activity, the antibody was
diluted 1 :20 and then incubated with aliquots ofIL-3 preparations or spleen cell-conditioned
medium for 1 h at 37 °C immediately before testing in the chemotaxis assay.
Cells.
￿
CTMC were isolated from peritoneal lavages ofC57BL/6 mice by centrifugation
on metrizamide gradients as described byHamguchi et al . (2) . Purity ofthe mast cell popula-
tion was >95% in all cases . The cells were washed and suspended in serum-freeOpti-MEM-I
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medium (Gibco Laboratories) containing 1.0% BSA (Boehringer Mannheim Biochemicals,
Indianapolis, IN). Peritoneal macrophages were activated in vivo with thioglycollate or pro-
teose peptone 3 d before isolation from peritoneal cavities (11). Cells that were adherent to
uncoated plastic culture dishes 1 h after isolation were collected by gentle scraping with a
rubber spatula, washed with Opti-MEM-I medium, and used immediately in migration assays.
Migration Assay.
￿
Chemoattraction was evaluated using a modified Boyden chamber assay
(12) in a 48-well chemotaxis chamber (Neuro Probe, Inc., Cabin John, MD). The agents
to be tested were diluted and added to the lower wells of the chamber. The wells were then
covered with two polycarbonate membranes, a lower 5-Am porosity membrane and an upper
12-pm membrane that was precoated for 30 min at room temperature in 15 ml ofPBS con-
taining 100 I~g laminin (Advanced Biotechnologies Inc., Silver Spring, MD) to promote mast
cell adhesion to the filter. 5,000 cells in 50 pl of medium were placed in the upper wells of
the chamber, and the entire apparatus was incubated at 37°C in a 5% C02 environment.
After 3 h, cells adhering to the upper surface of the filter were removed by scraping with
a rubber blade. Migrating cells that were adherent to the lower side of the 12-/Am filter and
cellsthat had passed through the upper filter and were caught on the lower 5-Wm filter were
incubated overnight in Carnoy's fixative and subsequently stained for 2 min at 25°C in 0.1%
toluidine blue (Polysciences, Inc., Warrington, PA). The filters were then mounted between
two glass slides in 90% glycerin, and the number of mast cells per well that had migrated
across the filter was determined by counting the mast cells remaining on each filter.
Results and Discussion
Because PWM-stimulated spleen cells produce factors that promote mast cell
proliferation, we investigated whether SCCM also contained mast cell chemoattrac-
tant activity. Our results reveal that SCCM stimulates mast cell migration with half-
maximal activity at 20% (vol/vol) (Fig. 1). Only cells with toluidine blue-staining
granules that had the morphological characteristics ofmast cellswere scored as posi-
tive in the migration assay. Greater than 90% ofthe mast cellsthat migrated across
the filters remained viable as determined by the ability to exclude trypan blue. Visible
signs of mast cell degranulation were not apparent at the end of the 3-h assay.
IL-3 and IL-4 are known to be produced by activated spleen cells. We therefore
tested these agents for their ability to stimulate CTMC migration. As shown in Fig.
1 B, murine IL-3 stimulates CTMC migration with half-maximal activity at a con-
centration of 8 U/ml. IL-3 elicits a dose-dependent sigmoidal response character-
istic ofcellular chemotaxis in which increasingthe concentration beyond that producing
maximal activity results in a decrease in cell motility. IL-4, in contrast, does not
stimulate mast cell migration (Fig. 1 B).
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FIGURE 1.
￿
Mast cell migration
in responseto serum-free PWM-
SCCM and IL-3 and IL-4. Che-
motactic response was defined
as the number of cells that tra-
versed the filter in response to
a test substance in the lower
well, minusthe number of cells
migrating in response to control
medium in both wells. In this
experiment, the subtractedback-
ground value was 42 cells. Data
points are expressed as the
mean +/- SEM; n = 3. (A) O,
SCCM. (B) O, IL-3; p, IL-4.MATSUURA AND ZETTER
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Because mixtures ofIL-3 andIL-4 have been shown to produceasynergistic stim-
ulation ofCTMC proliferation, we tested the ability of such mixtures to promote
CTMC migration. In theseexperiments, increasing concentrations ofIL-4 were added
to wells containing limiting concentrations (10 U/ml) of IL-3. As shown in Table
I, IL-4 was unable to potentiate the chemoattractant activity of IL-3.
In addition to IL-4, neitherrecombinantmurine IL-2, normurine GM-CSFhad
significantmastcell chemoattractantactivity (Table I). Both native and recombinant
IL-3, however, were active. All ofthe chemoattractant activity ofboth natural and
recombinant IL-3 preparations was inhibited by aneutralizing antibody(10) to mu-
rine IL-3. This antibody also blocked >90% ofthe activity ofthe spleen cell-condi-
tioned medium, suggesting that the majority ofthe mast cell chemoattractant ac-
tivity produced by activated spleen cells is directly due to the action of IL-3. The
antibodies to IL-3did notcauseanonspecific inhibitionofcellmotility because they
failed to block mast cell migration to Gly-His-Lys, apreviously described mast cell
chemoattractant(13). The chemotactic activity wasnot due to contaminating endo-
toxin as neither endotoxin nor boiled IL-3 were active.
TABLE I
Stimulation of Connective Tissue Mast Cell Migration
rm-IL-3 + anti-rm-IL-3
1 ng/ml
￿
10 t 6
10 ng/ml
￿
0
100 ng/ml
￿
0
(continued)
Treatment Chemotactic index"
nm-IL-3
1 U/ml 37 t 30
10 U/ml 194 t 32
100 U/ml 288 t 35
nm-IL-3 + anti-rm-IL-3
I U/ml 16 t 12
10 U/ml 5 t 5
100 U/ml 2 t 1
rm-IL-3
1 ng/ml 10 t 9
10 ng/ml 62 t 16
100 ng/ml 109 t 14
rm-IL-3 (boiled)
1 ng/ml 0
10 ng/ml 0
100 ng/ml 1 t 1
rm-IL-4
1 U/ml
10 U/ml
100 U/ml
5
3
0
t 6
t 2
rm-IL-3 (10 ng/ml) 62 t 16
rm-IL-3 + 1 U/ml IL-4 46 t 12
rm-IL-3 + 10 U/ml IL-4 66 t 14
rm-IL-3 + 100 U/ml IL-4 72 t 291424
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TABLE I (continued)
Treatment
￿
Chemotactic index"
Spleen cell CM
10%
￿
42 t 29
20%
￿
92 t 14
50%
￿
179 t 26
` Chemotactic index is the numberofcells that migrate across the filterin response
to an agent placed in the bottom well of the chemotactic chamber, minus the
number of cells that cross the filter in the absence ofany chemotactic agent.
This background is due to spontaneous random cell migration and varies from
40 to 100 cells/well. Data are expressed as mean number of migrating cells
over background (t SEM; n = 3). nm, natural murine; rm, recombinant
murine.
To determine whether the ability to respond to the chemotactic activity of IL-3
was a general property ofleukocytes, murine macrophages were isolatedfrommouse
peritoneal cavities andtested inthemultiwellchemotaxisassay. These cellsmigrated
in response to thebacterialchemoattractant N-formyl-methionyl-leucyl-phenylalanine
(f-MLF), but failed to respond to IL-3 (Table II). This result demonstrates that the
chemoattractant responsetoIL-3 showsspecificityand isnot shared byall celltypes.
Stimulated cell migration may be either directional (chemotaxis) or random
(chemokinesis). Thesecan be distinguished by varyingtheconcentrations ofchemoat-
tractant on each side of the filter in the assay chamber, as originally described by
Zigmond and Hirsch (14). Results of this type of"checkerboard" analysis, shown
in Table III, demonstrate that IL-3 primarily stimulates CTMC chemotaxis with
a minor chemokinetic component.
Spleen cell CM + anti-rm-IL-3
10%
20%
50%
12
21
13
t 9
t 11
t9
Gly-His-Lys
50 kg/ml 6 t 11
100 ug/ml 54 t 14
200 kg/ml 18 ± 5
Gly-His-Lys + anti-rm-IL-3
50 wg/ml 10 t 10
100 ug/ml 62 t 8
200 jug/ml 32 t 14
rm-IL-2
1 U/ml 1 t 1
10 U/ml 3 t 3
100 U/ml 0
rm-GM-CSF
1 U/ml 1 t 2
10 U/ml 8 t 7
100 U/ml 8 t 10
Endotoxin
1 ng/ml 7 t 7
10 ng/ml 0
100 ng/ml 0MATSUURA AND ZETTER
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TABLE II
Cellular Responsiveness to IL-3
Cell type
CTMC andperitoneal macrophages (PM) were isolated from mouse peritoneal
cavities as described in Materials and Methods. Migration assays were performed
as described in Materials and Methods, except that, for PM migration, a non-
coated 8-R filter was used in place of the 12-IA upper filter used in the mast cell
assay. Subtracted background values for unstimulated migration were 42 for
CTMC and 30 for PM .
TABLE III
Checkerboard Analysis of IL-3-induced Mast Cell Migration
Checkerboard analysis of CTMC migration. The indicated concentrations of
rm-IL-3 were added to the upper and lower wells of the multiwell chemotactic
chamber. Cell migration wasmeasured as described in Materials and Methods.
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Our currentresultsdemonstrate thatIL-3 releasedby spleen cellscaninduce CTMC
chemotaxis. This activity may, in part, account forthe increase in cell number as-
sociated with certainimmune reactions. The recent observationthat activatedmast
cells can be induced to produce IL-3 (15) further suggests that mast cells may be
capableofautoregulation ofboth growth andmotilitybyalteringtheenvironmental
concentration of this essential lymphokine.
Summary
PWM-activatedspleen cell-conditoned medium(SCCM) and avarietyofpurified
hematopoietic growth factors were tested for their ability to stimulate chemotaxis
ofmouse connective tissue mastcells (CTMC). Ofthe agents tested, only IL-3 and
SCCM promoted mast cell chemotaxis. Neither IL-2, IL-4, GM-CSF, nor endo-
toxin had any significant mast cell chemotactic activity. Neutralizing antibodies to
mouse IL-3 blocked >90% of the chemotactic activity ofSCCM, suggesting that
IL-3 is the predominant mast cell chemotactic factor produced by activated spleen
cells. Ourresults demonstratethatmature connectivetissue typemast cellsarecapable
CTMC PM
rm-IL-3
1 U/ml 10 1 9 2 t 2
10 U/ml 62 t 16 1 t 1
100 U/ml 109 1 14 7 1 3
fMLF
10-s 0 65 t 4
10-7 0 86 t 7
10-6 413 391 7
IL-3 in
lower well
ng/ml
0
IL-3 (ng/ml) in
1
upper well
10 100
0 33 t9 331 17 3316 4012
1 33 t8 741 7 6915 601 19
10 78 t 18 87 t 35 88 t 7 70 t 19
100 134 t 26 95 t 36 68 t 18 85 t 171426
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of moving toward a gradient of spleen cell-derived IL-3 and suggest that movement
of mature mast cells toward lymphokines may influence the accumulation of mast
cells at sites of inflammatory or immune reactions.
We thank Dr. John Abrams (DNAX, Palo Alto, CA) for his generous gift of neutralizing
antibody 19B3.1 to murine IL-3 and Dr. S. Galli (Beth Israel Hospital, Boston, MA) for his
helpful comments on this manuscript.
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